Article
Exploiting KRAS-driven Ferroaddiction in Cancer Through Ferrous Iron-Activatable Drug…
bioRxiv · 2021 · Honglin Jiang
Key facts
| Title | Exploiting KRAS-driven Ferroaddiction in Cancer Through Ferrous Iron-Activatable Drug Conjugates (FeADC) |
|---|---|
| First author | Honglin Jiang |
| Journal | bioRxiv |
| Published | Jun 4, 2021 |
| DOI | 10.1101/2020.05.12.088971 |
| Devices mentioned | K002611, K003613, K003946, K012875, K013636, K022397, K081028, K142098, K163619, K171128, K183231, K201615 and 20 more |
| Product codes mentioned | IZI, KIS, KPS, LLZ, LNH, MOS, OUO |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1